No Data
No Data
Hong Kong Stock Afternoon Review | The three major indices of Hong Kong stocks pulled back, and the Tech Index fell nearly 2%; PV stocks reversed the market, and GCL Technology rose more than 6%
Technology Network stocks declined; Bilibili fell more than 6%, NetEase fell more than 4%, Kuaishou and Meituan fell nearly 4%; as concept stocks declined, Huazhu Group fell more than 3%, and Jiumaojiu fell nearly 3%.
Intraday Overview | The three major indices of Hong Kong stocks surged and fell, and GCL Technology rose more than 6%
Apple concept stocks rose; BYD Electronics rose nearly 4%; Shunyu Optical Technology rose nearly 3%; gold stocks strengthened, Shandong gold rose nearly 3%, and China Gold International rose more than 2%.
Opinions | There is still room for Hong Kong stocks
In terms of industry choices, growth styles are spreading, and the Internet, semiconductors, automobiles, and pharmaceuticals may dominate, but high dividends are still valuable.
Futu Morning Post | The Federal Reserve's “Big Three” Release Pigeons: Interest Rates Will Eventually Be Cut; Tesla Reported to Begin a New Round of Layoffs
Federal Reserve Barkin: The current interest rate level has been able to reduce inflation to 2%; news: Apple is developing artificial intelligence chips for servers; Lucid's loss per share in the first fiscal quarter was higher than expected.
Opinion | How much room is left for Hong Kong stocks after two weeks of sharp gains? Optimistic estimate: 20%!
If subsequent policies continue to be effective, profit growth of 10% under optimistic conditions will correspond to an increase of about 20%.
Hong Kong Internet healthcare stocks continued to rise in the afternoon. Ali Health rose more than 9%, Jingdong Health rose nearly **** An Good Doctor rose nearly 8%, and Zhongan Online and Jingdang Health both rose more than 4%.
Hong Kong Internet healthcare stocks continued to rise in the afternoon. Ali Health rose more than 9%, Jingdong Health rose nearly **** An Good Doctor rose nearly 8%, and Zhongan Online and Jingdang Health both rose more than 4%.
No Data